1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-11.25
Negative P/E while CRON.TO shows 4.39. Joel Greenblatt would examine path to profitability versus competitor.
6.21
P/S less than half of CRON.TO's 25.33. Joel Greenblatt would verify if margins support this discount.
0.41
P/B 50-75% of CRON.TO's 0.72. Bruce Berkowitz would examine if asset composition explains the gap.
65.81
P/FCF less than half of CRON.TO's 191.29. David Dodd would verify if cash flow quality justifies this discount.
45.90
P/OCF less than half of CRON.TO's 99.41. David Dodd would verify if operating efficiency justifies this discount.
0.41
Fair value ratio 50-75% of CRON.TO's 0.72. Bruce Berkowitz would examine if business quality explains the gap.
-2.22%
Negative earnings while CRON.TO shows yield of 5.70%. Joel Greenblatt would examine path to profitability.
1.52%
FCF yield exceeding 1.5x CRON.TO's 0.52%. David Dodd would verify if cash flow quality justifies this premium.